Oldfield Edward H, Vance Mary Lee, Louis Robert G, Pledger Carrie L, Jane John A, Lopes Maria-Beatriz S
Department of Neurological Surgery (E.H.O., R.G.L., C.L.P., J.A.J), Department of Medicine (M.L.V.), and Department of Pathology (M.-B.S.L.), University of Virginia Health System, Charlottesville, VA 22903.
J Clin Endocrinol Metab. 2015 Aug;100(8):3165-71. doi: 10.1210/JC.2015-2493. Epub 2015 Jul 6.
Although Crooke's changes in the pituitary corticotrophs were initially described in 1935, the prevalence in which the changes occur in patients with Cushing's syndrome (CS) has not been established.
This study aimed to determine the prevalence and assess clinical features associated with the presence or absence of Crooke's changes in a large set of patients with CS.
Information from a prospective computer database and retrospective chart review was analyzed.
The setting was an academic medical center.
Consecutive patients (N = 213) who received surgery with a preoperative diagnosis of Cushing's disease are included.
The patients received pituitary surgery and specimens obtained underwent pathological analysis.
The presence or absence of Crooke's changes was determined by histopathological analysis of the normal pituitary tissue included with the specimen obtained at surgery. Cortisol production was measured by 24-hour urine cortisol production.
Crooke's changes occurred in 144 of 177 patients (81%) with a histologically demonstrated ACTH-staining tumor and in 74% of 213 patients diagnosed with CS who had pituitary surgery. The presence of Crooke's changes correlated with the finding of an ACTH-staining tumor removed at surgery and with the degree of hypercortisolism. Among patients with histologically established ACTH-staining tumors the prevalence of Crooke's changes was particularly high in patients with a 24-h urinary free cortisol (UFC) of at least 4-fold the upper limit of normal, in which 91% of patients had Crooke's changes, compared with 74% of patients whose maximum UFC was less than 4-fold the upper limit of normal (P = .008).
Crooke's changes occur in 75-80% of patients with CS, and depend on the degree of hypercortisolism and individual variability. Almost all patients with UFC at least 4-fold the upper limit of normal have them, whereas with less severe hypercortisolism the expression of Crooke's changes varies from person to person.
尽管垂体促肾上腺皮质激素细胞的克鲁克变化最初于1935年被描述,但库欣综合征(CS)患者中出现这种变化的患病率尚未确定。
本研究旨在确定一大组CS患者中克鲁克变化的患病率,并评估与克鲁克变化存在与否相关的临床特征。
分析来自前瞻性计算机数据库和回顾性病历审查的信息。
一家学术医疗中心。
纳入连续213例术前诊断为库欣病并接受手术的患者。
患者接受垂体手术,获取的标本进行病理分析。
通过对手术获取标本中包含的正常垂体组织进行组织病理学分析来确定克鲁克变化的有无。通过24小时尿皮质醇生成量来测量皮质醇分泌。
177例经组织学证实有促肾上腺皮质激素染色肿瘤的患者中有144例(81%)出现克鲁克变化,在213例接受垂体手术的CS诊断患者中有74%出现该变化。克鲁克变化的存在与手术切除的促肾上腺皮质激素染色肿瘤的发现以及皮质醇增多症的程度相关。在组织学确诊有促肾上腺皮质激素染色肿瘤的患者中,24小时尿游离皮质醇(UFC)至少为正常上限4倍的患者中克鲁克变化的患病率特别高,其中91%的患者有克鲁克变化,而最大UFC小于正常上限4倍的患者中这一比例为74%(P = 0.008)。
75 - 80%的CS患者会出现克鲁克变化,且取决于皮质醇增多症的程度和个体差异。几乎所有UFC至少为正常上限4倍的患者都会出现这种变化,而在皮质醇增多症不太严重的情况下,克鲁克变化的表现因人而异。